The Drugs for Neglected Diseases Initiative is a not-for-profit drug development organization created to improve the health and quality of life of people suffering from neglected diseases, such as human African trypanosomiasis, leishmaniasis, Chagas disease, and malaria. These diseases fall outside the existing systems and market mechanisms for research and development of drugs.

DNDi’s primary goals are to: 1) Develop new field-relevant treatments for people suffering from neglected diseases; 2) Raise awareness through advocacy on research and development of drugs for neglected diseases; and 3) Strengthen existing research capabilities in countries where neglected diseases are endemic.